BioSpace News Archive

NovaBay® Pharmaceuticals, Inc. reports financial results for the three months ended March 31, 2022 and provides a business update.

Gelesis, the maker of Plenity for weight management, reported financial results for the first quarter of 2022.

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology therapies, announced financial results for the three-month period ended March 31, 2022 and provided a corporate update.

Equillium, Inc. announced financial results for the first quarter 2022 and provided an update on its corporate development and clinical programs.

Viveve Medical, Inc. reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET.

Vor Bio, a clinical-stage cell and genome engineering company, reported financial results for the three-month period ended March 31, 2022, and provided a business update.

Xenetic Biosciences, Inc. reported its financial results for the first quarter of 2022 and provided a business update.

SAB Biotherapeutics reported financial results for the first quarter ended March 31, 2022, and provided a company update.

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today provided a business update and announced financial results for the first quarter of 2022, ended March 31, 2022.

AVITA Medical, Inc. reported financial results for its first quarter ended March 31, 2022.